Cargando…
Tarlatamab: the promising immunotherapy on its way from the lab to the clinic
Autores principales: | Tang, Daolin, Kang, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326778/ https://www.ncbi.nlm.nih.gov/pubmed/37425422 http://dx.doi.org/10.21037/tlcr-23-115 |
Ejemplares similares
-
Tarlatamab: a potential new option for recurrent small cell lung cancer
por: Addeo, Alfredo, et al.
Publicado: (2023) -
PARP inhibition and immunotherapy: a promising duo in fighting cancer
por: Phillipps, Jordan, et al.
Publicado: (2023) -
It’s a long way to the top (if you want to personalize immunotherapy)
por: Haebe, Sarah, et al.
Publicado: (2017) -
Taking it up a notch: a promising immunotherapy against small cell lung cancer
por: Apaydin, Alanisse A., et al.
Publicado: (2023) -
Faecal microbiota transplantation, a promising way to treat colorectal cancer
por: Ma, Yanru, et al.
Publicado: (2019)